Thyroid hormone in the frontier of cell protection, survival and functional recovery
Author
dc.contributor.author
Videla Cabrera, Luis
Author
dc.contributor.author
Fernández Arancibia, Virginia
Author
dc.contributor.author
Cornejo, Pamela
Author
dc.contributor.author
Vargas, Romina
Author
dc.contributor.author
Castillo Montecinos, Iván
Admission date
dc.date.accessioned
2016-01-14T13:40:11Z
Available date
dc.date.available
2016-01-14T13:40:11Z
Publication date
dc.date.issued
2015
Cita de ítem
dc.identifier.citation
Expert Reviews in Molecular Medicine Volumen: 17 Número de artículo: e10 May 2015
en_US
Identifier
dc.identifier.issn
1462-3994
Identifier
dc.identifier.other
DOI: 10.1017/erm.2015.8
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/136505
General note
dc.description
Artículo de publicación ISI
en_US
General note
dc.description
Sin acceso a texto completo
Abstract
dc.description.abstract
Thyroid hormone (TH) exerts important actions on cellular energy metabolism, accelerating O-2
consumption with consequent reactive oxygen species (ROS) generation and redox signalling
affording cell protection, a response that is contributed by redox-independent mechanisms. These
processes underlie genomic and non-genomic pathways, which are integrated and exhibit
hierarchical organisation. ROS production led to the activation of the redox-sensitive transcription
factors nuclear factor-kappa B, signal transducer and activator of transcription 3, activating protein 1
and nuclear factor erythroid 2-related factor 2, promoting cell protection and survival by TH. These
features involve enhancement in the homeostatic potential including antioxidant, antiapoptotic,
antiinflammatory and cell proliferation responses, besides higher detoxification capabilities and
energy supply through AMP-activated protein kinase upregulation. The above aspects constitute
the molecular basis for TH-induced preconditioning of the liver that exerts protection against
ischemia-reperfusion injury, a strategy also observed in extrahepatic organs of experimental
animals and with other types of injury, which awaits application in the clinical setting. Noteworthy,
re-adjusting TH to normal levels results in several beneficial effects; for example, it lengthens the
cold storage time of organs for transplantation from brain-dead donors; allows a superior
neurological outcome in infants of <28 weeks of gestation; reduces the cognitive side-effects of
lithium and improves electroconvulsive therapy in patients with bipolar disorders